Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy

OBJECTIVES: It has been proposed that the combination of thiazolidinedione (TZD) therapy to metformin and sulfonylurea is beneficial due to each medication having a unique mechanism of action. Within the Veterans Affairs Hospital, specific criteria of use define when TZD therapy can be initiated. Mo...

Descripción completa

Detalles Bibliográficos
Autores principales: McFarland, M. Shawn, Huddleston, Lana, Tammareddi, Kumar, McKenzie, Michael, Bean, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980726/
https://www.ncbi.nlm.nih.gov/pubmed/27536426
http://dx.doi.org/10.3109/21556660.2012.707996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980726/
https://www.ncbi.nlm.nih.gov/pubmed/27536426
http://dx.doi.org/10.3109/21556660.2012.707996

Ejemplares similares